Natixis Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.44M Sell
71,396
-1,235
-2% -$143K 0.01% 778
2026
Q1
$8.68M Sell
72,631
-203,297
-74% -$26.7M 0.01% 700
2025
Q4
$37.6M Sell
275,928
-101,285
-27% -$14.6M 0.05% 322
2025
Q3
$55.6M Sell
377,213
-15,922
-4% -$2.21M 0.08% 233
2025
Q2
$50.9M Buy
393,135
+60,837
+18% +$7.37M 0.08% 246
2025
Q1
$39.7M Buy
332,298
+244,410
+278% +$30.3M 0.07% 274
2024
Q4
$10.2M Sell
87,888
-20,289
-19% -$2.57M 0.02% 649
2024
Q3
$14.6M Sell
108,177
-38,292
-26% -$5.12M 0.03% 534
2024
Q2
$19.9M Buy
146,469
+39,735
+37% +$5.41M 0.04% 383
2024
Q1
$13.8M Buy
106,734
+1,975
+2% +$239K 0.03% 501
2023
Q4
$12M Sell
104,759
-7,633
-7% -$762K 0.03% 513
2023
Q3
$10.2M Buy
112,392
+14,973
+15% +$1.54M 0.03% 504
2023
Q2
$11M Buy
97,419
+17,781
+22% +$1.88M 0.03% 490
2023
Q1
$8.34M Buy
79,638
+7,577
+11% +$791K 0.03% 557
2022
Q4
$7.97M Sell
72,061
-8,665
-11% -$908K 0.03% 541
2022
Q3
$7.05M Buy
80,726
+11,604
+17% +$1.05M 0.03% 528
2022
Q2
$5.4M Buy
69,122
+30,026
+77% +$2.48M 0.02% 631
2022
Q1
$3.33M Buy
39,096
+11,519
+42% +$1.1M 0.01% 809
2021
Q4
$3.31M Sell
27,577
-2,899
-10% -$360K 0.01% 814
2021
Q3
$3.77M Buy
30,476
+5,178
+20% +$666K 0.02% 731
2021
Q2
$3.04M Buy
25,298
+3,187
+14% +$364K 0.01% 785
2021
Q1
$2.33M Buy
22,111
+3,310
+18% +$336K 0.01% 822
2020
Q4
$1.91M Sell
18,801
-1,696
-8% -$159K 0.01% 851
2020
Q3
$1.72M Sell
20,497
-603
-3% -$46.9K 0.01% 834
2020
Q2
$1.37M Sell
21,100
-47,722
-69% -$3.15M 0.01% 893
2020
Q1
$4.48M Buy
68,822
+11,704
+20% +$922K 0.04% 485
2019
Q4
$4.5M Buy
57,118
+8,329
+17% +$648K 0.03% 569
2019
Q3
$3.88M Buy
48,789
+8,773
+22% +$689K 0.03% 565
2019
Q2
$3.35M Buy
40,016
+7,873
+24% +$627K 0.03% 597
2019
Q1
$2.54M Buy
32,143
+5,252
+20% +$383K 0.02% 685
2018
Q4
$1.79M Sell
26,891
-1,936
-7% -$134K 0.02% 747
2018
Q3
$2.3M Buy
28,827
+2,801
+11% +$209K 0.02% 729
2018
Q2
$1.75M Buy
26,026
+11,747
+82% +$853K 0.02% 793
2018
Q1
$1.1M Sell
14,279
-2,228
-13% -$165K 0.01% 893
2017
Q4
$1.13M Sell
16,507
-1,660
-9% -$110K 0.01% 856
2017
Q3
$1.14M Sell
18,167
-3,502
-16% -$209K 0.01% 848
2017
Q2
$1.2M Buy
21,669
+7,911
+58% +$412K 0.01% 825
2017
Q1
$691K Sell
13,758
-1,298
-9% -$63.3K 0.01% 927
2016
Q4
$746K Sell
15,056
-1,770
-11% -$89.7K 0.01% 893
2016
Q3
$883K Sell
16,826
-3,105
-16% -$152K 0.01% 826
2016
Q2
$890K Buy
19,931
+2,379
+14% +$103K 0.01% 808
2016
Q1
$718K Buy
17,552
+629
+4% +$23.2K 0.01% 848
2015
Q4
$618K Buy
16,923
+2,019
+14% +$73K 0.01% 846
2015
Q3
$490K Buy
14,904
+3,134
+27% +$105K 0.01% 893
2015
Q2
$436K Sell
11,770
-25
-0.2% -$909 0.01% 930
2015
Q1
$413K Sell
11,795
-664
-5% -$23.4K 0.01% 937
2014
Q4
$474K Buy
12,459
+1,256
+11% +$45.9K 0.01% 930
2014
Q3
$398K Buy
11,203
+192
+2% +$7.13K 0.01% 937
2014
Q2
$430K Buy
11,011
+192
+2% +$7.17K 0.01% 1039
2014
Q1
$394K Buy
10,819
+1,621
+18% +$59.1K 0.01% 1000
2013
Q4
$318K Sell
9,198
-23,570
-72% -$758K 0.01% 1007
2013
Q3
$915K Buy
32,768
+2,098
+7% +$55.9K 0.02% 699
2013
Q2
$827K Buy
+30,670
New +$847K 0.02% 708

Other funds holding XYL

Natixis Advisors's XYL Position: Q2 2026 in Review

Natixis Advisors reduced its Xylem (XYL) stake by 1.7% in Q2 2026, selling an estimated $143K and leaving 71,396 shares worth $8.44M. The position accounts for 0.01% of the portfolio, ranked #778.

Natixis Advisors first reported a position in XYL in Q2 2013 and has held it in 53 quarters since. The position peaked at $55.6M in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Natixis Advisors held 71,396 shares of Xylem worth $8.44M as of Q2 2026.
  • Natixis Advisors sold 1,235 Xylem shares in Q2 2026, an estimated $143K.
  • Xylem made up 0.01% of Natixis Advisors's portfolio in Q2 2026, its #778 holding.
  • Natixis Advisors first reported a position in Xylem in Q2 2013 and has held it in 53 quarters since.
  • Natixis Advisors's Xylem position peaked at $55.6M in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.